Roche has introduced the new cobas e 801 module to help hospitals meet the demand for increased diagnostic testing.
The new high-volume testing immunoassay solution is now available in all CE mark accepting countries.
The module provides more than 100 immunoassays across a range of disease areas. With a high uptime, the cobas e 801 enables continuous loading of reagents and consumables.
It can configure up to four modules, providing flexibility to deliver 1’200 tests per hour across up to 192 reagent positions.
Featuring Elecsys technology, the module takes 18 minutes for routine and nine minutes for emergency tests.
Roche Diagnostics CEO Roland Diggelmann said: "Today, laboratories need to deliver more diagnostic tests than ever before, while in many cases their resources are constrained.
"The cobas e 801 module is an important part of Roche’s connected laboratory solutions that allows laboratories to test efficiently and to sustainably grow their testing capacity."
In May, Roche introduced new CoaguChek INRange system self-testing device, which helps patients to spend more time in therapeutic range with minimal training.
The Bluetooth enabled PT/INR home health device allows remote care programmes for anticoagulated patients.